A meta-analysis of these trials confirmed the efficacy of ablation in reducing the burden of recurrent atrial arrhythmias as a second-line therapy, with a 63% reduction in the risk of recurrence compared to drug therapy (risk ratio 0.37; 95% confidence interval [CI] 0.29–0.48; P < . 00001).